Hemoglobin S polymerization inhibitor

This page covers all Hemoglobin S polymerization inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Hemoglobin S (HbS).

Targets

Hemoglobin S (HbS)

Marketed (1)

• Oxbryta · Pfizer Inc. · Hematology · 250
  Hemoglobin S polymerization inhibitor that binds HbS 1:1 and increases oxygen affinity.